Axitan CEO discusses endolysins and the dramatic early life impact of FORC3 with The Poultry Site

Sarah Mikesell, The Poultry Site Editor’s Note: As previously reported, Axitan has developed a ground breaking approach for addressing economically important bacteria that impact the livestock industry by using naturally occurring antimicrobial enzymes, known as endolysins. I thought it would be timely to check in with their new CEO, Al Zimmerman, to see how things are progressing with their first product, FORC3®, which has been developed to target Clostridium perfringens, the bacteria that causes necrotic enteritis in poultry.

The article can be found here